December 30, 2005
United States pharmaceutical company Wyeth, which made Taiwan one of its four regional operations and management centers around the world in 2000, has achieved its first-stage goals for the center by expanding its scope to cover fourteen Asian countries, including Australia and Japan. Wyeth Taiwan says that its next goal is to put
NTD 700 million into the final-stage production of vaccination and protein-based drugs. With this goal in mind, Wyeth Taiwan has already started planning for the construction of a new warehouse and distribution center.
Wyeth Taiwan first began supplying the Australian market in September 2004 and the Japanese market in August of this year.
Wyeth's increased exports to Australia have boosted Taiwanese drug exports by 42% in the first three quarters of the year, according to the Industrial Technology Research Institute's Industrial Economics and Knowledge Center. The center predicts that, when Wyeth further expands exports to Japan in 2006, Taiwan's pharmaceutical exports will grow by over
NTD 200 million.
Pleased with the major contributions Wyeth has made to Taiwan's pharmaceutical industry, the government is also working to encourage major international drug makers GlaxoSmithKline and Novartis to establish research centers in Taiwan.
(United Daily News)
E-mail this page.
Invest in Taiwan
